Literature DB >> 18757621

Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others.

A Blümle1, G Antes, M Schumacher, H Just, E von Elm.   

Abstract

BACKGROUND: Only data of published study results are available to the scientific community for further use such as informing future research and synthesis of available evidence. If study results are reported selectively, reporting bias and distortion of summarised estimates of effect or harm of treatments can occur. The publication and citation of results of clinical research conducted in Germany was studied.
METHODS: The protocols of clinical research projects submitted to the research ethics committee of the University of Freiburg (Germany) in 2000 were analysed. Published full articles in several databases were searched and investigators contacted. Data on study and publication characteristics were extracted from protocols and corresponding publications.
RESULTS: 299 study protocols were included. The most frequent study design was randomised controlled trial (141; 47%), followed by uncontrolled studies (61; 20%), laboratory studies (30; 10%) and non-randomised studies (29; 10%). 182 (61%) were multicentre studies including 97 (53%) international collaborations. 152 of 299 (51%) had commercial (co-)funding and 46 (15%) non-commercial funding. 109 of the 225 completed protocols corresponded to at least one full publication (total 210 articles); the publication rate was 48%. 168 of 210 identified publications (80%) were cited in articles indexed in the ISI Web of Science. The median was 11 citations per publication (range 0-1151).
CONCLUSIONS: Results of German clinical research projects conducted are largely underreported. Barriers to successful publication need to be identified and appropriate measures taken. Close monitoring of projects until publication and adequate support provided to investigators may help remedy the prevailing underreporting of research.

Mesh:

Year:  2008        PMID: 18757621     DOI: 10.1136/jme.2008.024521

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  23 in total

1.  Are results from pharmaceutical-company-sponsored studies available to the public?

Authors:  Rafael Dal-Ré; Alejandro Pedromingo; Manuel García-Losa; Juan Lahuerta; Rafael Ortega
Journal:  Eur J Clin Pharmacol       Date:  2010-09-16       Impact factor: 2.953

2.  [The urological trial registry of the German Society of Urology].

Authors:  F Kunath; C Becker; S Jena; G Antes; B Wullich
Journal:  Urologe A       Date:  2011-04       Impact factor: 0.639

3.  Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity.

Authors:  C Nieder
Journal:  Strahlenther Onkol       Date:  2012-08-23       Impact factor: 3.621

Review 4.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279

5.  Publication bias in diagnostic imaging: conference abstracts with positive conclusions are more likely to be published.

Authors:  Lee Treanor; Robert A Frank; Lindsay A Cherpak; Ana Dehmoobad Sharifabadi; Jean-Paul Salameh; Zachary Hallgrimson; Nicholas Fabiano; Trevor A McGrath; Noemie Kraaijpoel; Jason Yao; Daniel A Korevaar; Patrick M Bossuyt; Matthew D F McInnes
Journal:  Eur Radiol       Date:  2020-01-17       Impact factor: 5.315

6.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies.

Authors:  Fujian Song; Sheetal Parekh-Bhurke; Lee Hooper; Yoon K Loke; Jon J Ryder; Alex J Sutton; Caroline B Hing; Ian Harvey
Journal:  BMC Med Res Methodol       Date:  2009-11-26       Impact factor: 4.615

Review 8.  A systematic review of clinical trials of pharmacological interventions for acute ischaemic stroke (1955-2008) that were completed, but not published in full.

Authors:  Lorna M Gibson; Miriam Brazzelli; Brenda M Thomas; Peter A G Sandercock
Journal:  Trials       Date:  2010-04-22       Impact factor: 2.279

9.  Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles.

Authors:  Anette Blümle; Joerg J Meerpohl; Gerta Rücker; Gerd Antes; Martin Schumacher; Erik von Elm
Journal:  BMJ       Date:  2011-04-05

10.  Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study).

Authors:  Benjamin Kasenda; Erik B von Elm; John You; Anette Blümle; Yuki Tomonaga; Ramon Saccilotto; Alain Amstutz; Theresa Bengough; Jörg Meerpohl; Mihaela Stegert; Kari A O Tikkinen; Ignacio Neumann; Alonso Carrasco-Labra; Markus Faulhaber; Sohail Mulla; Dominik Mertz; Elie A Akl; Dirk Bassler; Jason W Busse; Ignacio Ferreira-González; Francois Lamontagne; Alain Nordmann; Rachel Rosenthal; Stefan Schandelmaier; Xin Sun; Per O Vandvik; Bradley C Johnston; Martin A Walter; Bernard Burnand; Matthias Schwenkglenks; Heiner C Bucher; Gordon H Guyatt; Matthias Briel
Journal:  BMC Med Res Methodol       Date:  2012-08-28       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.